-The Times of India NEW DELHI: As online shopping catches up, you could buy medicines too with a click of the mouse for which the health ministry is evaluating a proposal. The drug quality regulator is framing guidelines and mechanism to monitor such sale. The proposal is expected to be taken up for discussion in the drugs consultative committee meeting next month, a senior regulatory official said. At present, the Drugs & Cosmetics...

-The Hindu The Department of Personnel and Training (DoPT), under the instructions of the Prime Minister’s Office, has undertaken a pilot project to implement the Gujarat human resources management model in two Central government agencies. The proposal for System of Application of Technology for Human Resources Improvement (SATHI) application was approved by the then Gujarat Chief Minister Narendra Modi in 2012, developed by IT major Infosys and launched by Chief Minister Anandiben...

-The Indian Express Recently, the Central government invited comments on its Draft National Health Policy (DNHP). The DNHP provides an exhaustive coverage of health issues and challenges facing this much neglected sector. Its major recommendations are making health a justiciable right and denial of care an offence; provisioning of health services through a strengthened public health delivery system in partnership with the private sector; enhancing public spending from the current level...

-Economic and Political Weekly The key to improving the quality of healthcare services in India and reducing costs at the same time can be found by enacting legislation which lays down minimum standards of patient care. In the absence of such standards and the reluctance of health insurance companies to standardise either price or quality, healthcare services continue to be expensive and of doubtful quality. Developing standards of patient care by...

-Business Standard Domestic regulators need to be stricter about quality violations to protect both Indian pharma exports as well as the country's image Even as major Indian drug companies continue to make news for impurities in the medicines they make and faulty - or if the USFDA is to be believed, falsified - data that many generate after testing of samples show quality problem, it seems strange that domestic authorities are silent...